Similarly, analysis of PGC-1α inhibition in the Cancer Dependency Map (DepMap) revealed a stronger anti-proliferative effect in SCLC compared with NSCLC (Fig. 3D). The gene discussed is PPARGC1A; the disease is small cell lung carcinoma.